PDB60 IMPACT OF THE ANEMIA: SOCIO-ECONOMIC INEQUITIES ANALYZING THE DEMOGRAPHY AND FAMILY HEALTH SURVEY IN PERU

Abstract

Estimate the costs, public spending and socio-economic inequities of anemia in the Public Health System of Peru Cross-sectional study based on ENDES 2018. A partial economic evaluation of disease cost type (EC) was carried out. The study population was a cohort 11,377 children under 36 months. The costs were estimated from the perspective of the funder taken for the year 2018. The definition of clinical management schemes (medical procedures and medications for the diagnosis, treatment and monitoring of the disease) come from the Insurable Conditions of the Essential Insurance Plan in Health (PEAS). The hypothetical cohort of total children under 36 months with anemia in Peru is 1,225,466 for the year 2018 (Prevalence of anemia: 43.5%). The total cost to combat anemia would be USD 104,560,007.17 (unit cost USD 85.2), corresponding to diagnosis USD 53.3 (62.4%), treatment USD 10.8 (12.7%) and for follow-up USD 21.2 (24.9%). The fixed cost corresponded to USD 28.1 (39.9%) and the variable cost to USD 42.4 (60.1%). The public budget in the Articulated Nutrition Program for 2018 was USD 738,730,387.6. This amount represents 14% of the budget for the year 2018 in the results-based Budget Program called Nutritional Article. Anemia was higher in the rural area (50.9%), Andean population (50.2%) and Amazon (50.5%), illiteracy by the mother (51.9%), the poor population (47.9%) and extremely poor (53.6 %) is the most affected and the beneficiaries of social programs (51.4%). Increasing the budget to combat anemia in Peru is a very relevant aspect, however this must be complemented by improvements in access to health services of the most vulnerable population, this will improve financing policies and invest in equity within the framework of universal health coverage in the country.